(EL) Estee Lauder Companies - Ratings and Ratios
Skincare, Makeup, Fragrance, Haircare, Tools
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.30% |
| Yield on Cost 5y | 0.59% |
| Yield CAGR 5y | 11.83% |
| Payout Consistency | 95.0% |
| Payout Ratio | 83.3% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 42.7% |
| Value at Risk 5%th | 60.9% |
| Relative Tail Risk | -13.30% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.95 |
| Alpha | 23.23 |
| CAGR/Max DD | -0.27 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.553 |
| Beta | 1.343 |
| Beta Downside | 1.684 |
| Drawdowns 3y | |
|---|---|
| Max DD | 81.40% |
| Mean DD | 53.09% |
| Median DD | 59.42% |
Description: EL Estee Lauder Companies December 17, 2025
The Estée Lauder Companies (NYSE: EL) designs, manufactures, markets, and sells prestige skin-care, makeup, fragrance, and hair-care products worldwide, operating through a mix of department stores, specialty retailers, e-commerce platforms, and direct-to-consumer channels.
Its portfolio spans 25+ brands-including La Mer, Jo Malone London, Tom Ford, Clinique, M·A·C, The Ordinary, Aveda, and Too Faced-covering the full spectrum of personal-care categories from moisturizers and serums to perfumes and styling products.
Distribution is highly diversified: high-end department stores and perfumeries, duty-free outlets, upscale salons and spas, as well as growing online pure-player sites and the company’s own e-commerce portals.
Key recent metrics (FY 2023) show net sales of roughly $17.7 billion, a 9 % year-over-year increase driven largely by a 22 % rise in Asia-Pacific sales, and adjusted EPS of $6.80, reflecting strong margin expansion in the digital channel.
Sector-wide, the prestige beauty market is buoyed by rising consumer spending on premium personal-care, accelerated digital adoption, and a shift toward “clean” and “inclusive” product narratives; however, macro-level risks include inflation-driven discretionary cutbacks and currency volatility in emerging markets.
For a deeper, data-driven valuation framework, you may find ValueRay’s analyst tools worth a look.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (-930.0m TTM) > 0 and > 6% of Revenue (6% = 866.5m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -0.85pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 11.29% (prev 11.19%; Δ 0.10pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 1.60b > Net Income -930.0m (YES >=105%, WARN >=100%) |
| Net Debt (7.20b) to EBITDA (451.0m) ratio: 15.97 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.32 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (363.3m) change vs 12m ago 1.03% (target <= -2.0% for YES) |
| Gross Margin 74.19% (prev 72.29%; Δ 1.90pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 71.06% (prev 72.48%; Δ -1.42pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.96 (EBITDA TTM 451.0m / Interest Expense TTM 398.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.09
| (A) 0.08 = (Total Current Assets 6.71b - Total Current Liabilities 5.08b) / Total Assets 19.33b |
| (B) 0.60 = Retained Earnings (Balance) 11.59b / Total Assets 19.33b |
| (C) -0.02 = EBIT TTM -381.0m / Avg Total Assets 20.32b |
| (D) 0.68 = Book Value of Equity 10.46b / Total Liabilities 15.44b |
| Total Rating: 3.09 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 26.07
| 1. Piotroski 2.50pt |
| 2. FCF Yield 2.36% |
| 3. FCF Margin 7.24% |
| 4. Debt/Equity 2.42 |
| 5. Debt/Ebitda 15.97 |
| 6. ROIC - WACC (= -10.26)% |
| 7. RoE -22.87% |
| 8. Rev. Trend -60.55% |
| 9. EPS Trend -50.08% |
What is the price of EL shares?
Over the past week, the price has changed by +3.75%, over one month by +26.18%, over three months by +23.47% and over the past year by +47.13%.
Is EL a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 23
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the EL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 102.2 | -5.4% |
| Analysts Target Price | 102.2 | -5.4% |
| ValueRay Target Price | 109.4 | 1.3% |
EL Fundamental Data Overview December 21, 2025
P/E Forward = 51.8135
P/S = 2.5604
P/B = 9.5213
P/EG = 2.0317
Beta = 1.175
Revenue TTM = 14.44b USD
EBIT TTM = -381.0m USD
EBITDA TTM = 451.0m USD
Long Term Debt = 7.32b USD (from longTermDebt, last quarter)
Short Term Debt = 418.0m USD (from shortTermDebt, last quarter)
Debt = 9.42b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.20b USD (from netDebt column, last quarter)
Enterprise Value = 44.19b USD (36.99b + Debt 9.42b - CCE 2.22b)
Interest Coverage Ratio = -0.96 (Ebit TTM -381.0m / Interest Expense TTM 398.0m)
FCF Yield = 2.36% (FCF TTM 1.04b / Enterprise Value 44.19b)
FCF Margin = 7.24% (FCF TTM 1.04b / Revenue TTM 14.44b)
Net Margin = -6.44% (Net Income TTM -930.0m / Revenue TTM 14.44b)
Gross Margin = 74.19% ((Revenue TTM 14.44b - Cost of Revenue TTM 3.73b) / Revenue TTM)
Gross Margin QoQ = 73.37% (prev 71.97%)
Tobins Q-Ratio = 2.29 (Enterprise Value 44.19b / Total Assets 19.33b)
Interest Expense / Debt = 0.91% (Interest Expense 86.0m / Debt 9.42b)
Taxrate = 56.88% (62.0m / 109.0m)
NOPAT = -164.3m (EBIT -381.0m * (1 - 56.88%)) [loss with tax shield]
Current Ratio = 1.32 (Total Current Assets 6.71b / Total Current Liabilities 5.08b)
Debt / Equity = 2.42 (Debt 9.42b / totalStockholderEquity, last quarter 3.89b)
Debt / EBITDA = 15.97 (Net Debt 7.20b / EBITDA 451.0m)
Debt / FCF = 6.89 (Net Debt 7.20b / FCF TTM 1.04b)
Total Stockholder Equity = 4.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -4.81% (Net Income -930.0m / Total Assets 19.33b)
RoE = -22.87% (Net Income TTM -930.0m / Total Stockholder Equity 4.07b)
RoCE = -3.35% (EBIT -381.0m / Capital Employed (Equity 4.07b + L.T.Debt 7.32b))
RoIC = -1.44% (negative operating profit) (NOPAT -164.3m / Invested Capital 11.37b)
WACC = 8.81% (E(36.99b)/V(46.41b) * Re(10.96%) + D(9.42b)/V(46.41b) * Rd(0.91%) * (1-Tc(0.57)))
Discount Rate = 10.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.46%
[DCF Debug] Terminal Value 58.55% ; FCFE base≈1.16b ; Y1≈761.7m ; Y5≈348.3m
Fair Price DCF = 18.62 (DCF Value 4.58b / Shares Outstanding 245.9m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -50.08 | EPS CAGR: -44.99% | SUE: 0.54 | # QB: 0
Revenue Correlation: -60.55 | Revenue CAGR: -11.65% | SUE: 0.05 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.73 | Chg30d=-0.045 | Revisions Net=-14 | Analysts=19
EPS current Year (2026-06-30): EPS=2.16 | Chg30d=+0.074 | Revisions Net=+20 | Growth EPS=+42.7% | Growth Revenue=+4.2%
EPS next Year (2027-06-30): EPS=2.92 | Chg30d=+0.066 | Revisions Net=+13 | Growth EPS=+35.6% | Growth Revenue=+3.9%
Additional Sources for EL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle